-
公开(公告)号：US20240199568A1
公开(公告)日：2024-06-20
申请号：US18512910
申请日：2023-11-17
Applicant: Enveric Biosciences Canada Inc.
Inventor： Kaveh Matinkhoo , David James Press , Glynnis Elizabeth Jensen , Charlie Cai , Jillian M. Hagel , Peter J. Facchini
IPC: C07D317/58 , C07D405/06
CPC classification number: C07D317/58 , C07D405/06
Abstract: Disclosed are novel fused mescaline derivative compounds, notably substituted N-propylamine fused heterocyclic mescaline derivatives, including substituted N-propylamine fused dioxolane mescaline derivatives, and pharmaceutical and recreational drug formulations containing the same. Methods of making and using these compounds are also disclosed.
-
公开(公告)号：US20240122950A1
公开(公告)日：2024-04-18
申请号：US18390195
申请日：2023-12-20
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: A61K31/675 , A61P25/18
CPC classification number: A61K31/675 , A61P25/18
Abstract: Disclosed are novel multi-substituent psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a substituent containing compound.
-
公开(公告)号：US11945778B2
公开(公告)日：2024-04-02
申请号：US18203823
申请日：2023-05-31
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Kaveh Matinkhoo , Peter J. Facchini
IPC: A61K31/4045 , A61P25/00 , C07D209/16 , C07D209/20 , C07D401/12 , C07D403/12 , C07D405/12
CPC classification number: C07D209/16 , A61K31/4045 , A61P25/00 , C07D209/20 , C07D401/12 , C07D403/12 , C07D405/12
Abstract: Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
-
公开(公告)号：US11891359B2
公开(公告)日：2024-02-06
申请号：US17955922
申请日：2022-09-29
Applicant: ENVERIC BIOSCIENCES CANADA INC.
Inventor： Jillian M. Hagel , Peter J. Facchini , Xue Chen
IPC: C07D209/16
CPC classification number: C07D209/16
Abstract: Disclosed are novel prenylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced in vitro or in vivo using a biosynthetic system which comprises cells comprising a prenyl transferase, and, optionally, additional enzymes, including a decarboxylase, and an N-acetyl transferase.
-
公开(公告)号：US20230295084A1
公开(公告)日：2023-09-21
申请号：US17885978
申请日：2022-08-11
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Ye Cai , Kaveh Matinkhoo , David James Press , Glynnis Elizabeth Jensen , Peter J. Facchini
IPC: C07D209/16
CPC classification number: C07D209/16
Abstract: Disclosed are novel C4-carboxylic acid-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
-
Patent Agency Ranking
公开(公告)号：US20230086396A1
公开(公告)日：2023-03-23
申请号：US17941425
申请日：2022-09-09
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: C07D209/20 , C07H17/02
Abstract: Disclosed are novel glycosylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a hydroxylated psilocybin derivative with a glycosyl compound.
-
公开(公告)号：US20250025483A1
公开(公告)日：2025-01-23
申请号：US18890082
申请日：2024-09-19
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: A61K31/675 , A61P25/18
Abstract: Disclosed are novel multi-substituent psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a substituent containing compound.
-
公开(公告)号：US12138276B2
公开(公告)日：2024-11-12
申请号：US18655793
申请日：2024-05-06
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini
IPC: A61K31/675 , A61K31/4045 , C12N9/02 , C12N9/10 , C12N9/12 , C12N15/52 , C12P17/10
Abstract: Disclosed are novel halogenated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced using a biosynthetic system which comprises cells comprising a psilocybin biosynthetic enzyme complement.
-
公开(公告)号：US12128058B2
公开(公告)日：2024-10-29
申请号：US18390195
申请日：2023-12-20
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: A61K31/675 , A61P25/18
CPC classification number: A61K31/675 , A61P25/18
Abstract: Disclosed are novel multi-substituent psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a substituent containing compound.
-
公开(公告)号：US12077498B2
公开(公告)日：2024-09-03
申请号：US18218216
申请日：2023-07-05
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Ye Cai , Kaveh Matinkhoo , David James Press , Glynnis Elizabeth Jensen , Peter J. Facchini
IPC: C07D209/16 , A61K31/4045 , A61P25/00 , C07D209/20 , C07D401/12 , C07D403/12 , C07D405/12
CPC classification number: C07D209/16 , A61K31/4045 , A61P25/00 , C07D209/20 , C07D401/12 , C07D403/12 , C07D405/12
Abstract: Disclosed are novel C4-carboxylic acid-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
-
-
-
-
-
-
-
-
-
Search Results
46
records
(took 0.015 seconds)
